| Catalyst | Drug/Treatment | Stage | Probability of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | -% | Small Molecule | Oncology | ||
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | -% | Small Molecule | Oncology | ||
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | -% | Small Molecule | Oncology |
Recent Updates
Recently added Catalysts
Organigram Global Inc. Common Shares$0.95
-0.01 (-0.85%)
0Pipeline Score NOT_PHARMA
Market Cap
190.87 M
EPS
0.11
P/E Ratio
14.35 $
Value Trade
320.54 K
%
Week
%
1 Month
%
3 Month
%
6 Month
%
5 Year
%
All Time
Cash Data
Cash Position
12.35 K
Monthly Burn
12.35 K
Runway
12,345 mo
Overview
Volume
289.05 K
52 Week Range
1 - 2.24
% held by Insiders
33.63 %
% held by Institutions
6.54 %
Enterprise Value
151.18 M
Total Shares
136.33 M
Short %
5.63 %
Float Shares
96.25 M
Company Description
locked
Upcoming Catalyst
Drug Pipeline Intelligence
0
Pipeline Score -
Pipeline ValueValuation Signal
0
Drugs Scored—
rNPV / MCap Top 1%
Micro Cap (rank 897 of 905)
Percentile RankClinical Trial Results
| Drug Name | Indications | Phase | Date | Trial Results Summary | Title | Source |
|---|---|---|---|---|---|---|
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | |||
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | |||
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 |
Inside Trades
YEARLY INSIDER TRANSACTIONS
Sector Avg.
INSIDERS
SOLDINSIDERS
BOUGHT
SOLDINSIDERS
BOUGHT
POSITIVE SENTIMENT Based on 22 Insiders Transactions
Hedge Funds
Shares Held
HEDGE FUNDS
SOLDHEDGE FUNDS
BOUGHT
SOLDHEDGE FUNDS
BOUGHT
POSITIVE SENTIMENT Based on 27 hedge funds in the last quarter
18 buying (3 new)·9 selling (1 exited)·2 unchanged
Hedge Funds invested in OGI
| HedgeFund Name ( 3 ) | % of Portfolio | Current MV - | Shares Owned - | Activity Avg Price $0 |
|---|---|---|---|---|
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K |
Organigram Global Inc. Common Shares (OGI) Analyst Ratings & Price Targets
Symbol
Firm
Rating
Action
Price Target
Upside
date
OGI
Example Securities
Buy
Initiated
$150.00
+25%
2026-01-15
OGI
Example Securities
Buy
Initiated
$150.00
+25%
2026-01-15
OGI
Example Securities
Buy
Initiated
$150.00
+25%
2026-01-15
OGI Stock Forecast & Analyst Consensus
BUY
Analyst Ratings
Buy65.0%
Hold25.0%
Sell10.0%
Price Target Trend
Average$24.00
Low$18.00
High$32.00
OGI Institutional Ownership Trends
Current Insider %
5.20%
—+0.00%
Current Institutional %
62.40%
—+0.00%
Total Ownership
67.60%
Insider + Institutional
Data Points
1
1 Ticker(s)
Option Chain Statistics
| Expiration | Volume | Open Interest | Implied Volatility Calls | Implied Volatility Puts | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Calls | Puts | Put-Call Ratio | Calls | Puts | Put-Call Ratio | IV | OiWaIv | VWaIv | IV | OiWaIv | VWaIv | |
| 2026-07-17 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
| 2026-07-17 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
| 2026-07-17 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last Price | Volume | Open Interest | Last Price | Volume | Open Interest | |
| No data available | ||||||
Open interest
Today's Open Interest
1.00 M
Put-Call Ratio
1.1
Put Open Interest
480.00 K
Call Open Interest
520.00 K
Open Interest Avg (30-day)
900,000
Today vs Open Interest Avg (30-day)
11.11%
Option Volume
Today's Volume
750.00 K
Put-Call Ratio
0.95
Put Volume
360.00 K
Call Volume
390.00 K
Volume Avg (30-day)
800,000
Today vs Volume Avg (30-day)
-6.25%
Company News
-OGI
Apr 15, 2026Organigram Closes Previously Announced Acquisition of Sanity Group, Private Placement Financing with BAT and ATB Senior Secured Credit Facilities
Organigram has finalized its acquisition of Sanity Group and completed a private placement financing with BAT. Additionally, the company secured senior secured credit facilities with ATB. These strategic moves are aimed at strengthening Organigram's market position and financial stability.
Read more →-OGI
Mar 9, 2026to, and incorporated by reference into, the Company's Annual Report on Form 40-F for the fiscal year ended
Organigram Global Inc. will hold an annual meeting on March 30, 2026, where shareholders will vote on the indirect acquisition of Sanity Group GmbH, a German cannabis company. This strategic transaction aims to expand Organigram's presence in the European market, leveraging Sanity's resources and expertise. The acquisition is expected to enhance profitability and market reach, pending shareholder and regulatory approvals. Despite its promising outlook, the timeline for the closing of the transaction remains uncertain.
Read more →-OGI
Feb 18, 2026Document Dated
The document titled 'Share Sale and Purchase Agreement' pertains to a transaction involving Sanity Group GmbH and various sellers including Organigram Global Inc. Details such as purchase conditions, warranties, and legal representations are outlined within the exhibit. Certain portions are redacted for confidentiality, with provisions for an unredacted version available to the SEC upon request. The exhibit spans formal agreements relating to shares and transactions pertinent to the involved parties.
Read more →-OGI
Dec 5, 2025pressreleased Organigram to Report Fourth Quarter Fiscal 2025 Results on
Organigram Global Inc. announced that it will report its earnings results for the fourth quarter of fiscal 2025 on December 16, 2025. The earnings report will cover results for the period ending September 30, 2025. A conference call is scheduled for the same day at 8:00 am ET, where company executives will discuss the results. The company is also noted for its wide array of cannabis brands and operations across several locations in Canada.
Read more →-OGI
Nov 25, 2025materialchang FORM 51-102F3 MATERIAL CHANGE REPORT ITEM 1 - Name and Address of Company Organigram Global Inc. (the "Company") 145 King Street West, Suite 1400 Toronto, ON, M5H 1J8 ITEM 2 - Date of Material Change
Organigram Global Inc. announced the appointment of James Yamanaka as the new Chief Executive Officer, effective around January 15, 2026. Yamanaka, previously Global Head of Strategy at British American Tobacco, brings over 20 years of industry experience. Peter Amirault will serve as the Executive Chair on an interim basis starting December 1, 2025, overseeing the company until Yamanaka assumes his role. This strategic change is viewed positively, enhancing the company's leadership with a focus on international expansion.
Read more →-OGI
Mar 26, 2025Document Organigram Unveils Bold New Brand Identity Reflecting Market Leadership Position in Canada and Growing International Presence
Organigram Holdings Inc. has rebranded to Organigram Global Inc., highlighting its transition from a regional to a global cannabis leader. With a focus on international expansion, the company aims to strengthen its market presence through strategic investments, including a partnership with German cannabis leader, Sanity Group. The new brand identity reflects Organigram’s commitment to innovation and excellence, driving its growth ambitions in key markets. The rebrand follows shareholder approval and aligns with its mission to deliver high-quality cannabis products globally.
Read more →-OGI
Mar 24, 2025Document Organigram Announces Results of Annual and Special Meeting, including Shareholder Approval of Name Change to Organigram Global Inc. TORONTO, Ontario - (BUSINESS WIRE)
Organigram Holdings Inc. announced the results from its virtual annual general and special meeting held on March 24, 2025, where shareholders approved a name change to Organigram Global Inc. by a significant majority of 95.778%. Additionally, the election of all ten nominees as directors was confirmed, indicating robust support for the company leadership. Committees were also established following the meeting, and PKF O'Connor Davies LLP was appointed as the company auditor. The change in name and other resolutions are pending regulatory approvals.
Read more →-OGI
Mar 3, 2025to, and incorporated by reference into, the Company s Annual Report on Form 40-F for the fiscal year ended
Organigram Holdings Inc. will hold its Annual General and Special Meeting of Shareholders on March 24, 2025, via a virtual-only platform. The meeting aims to provide expanded access to shareholders and will cover various company matters, including the receipt of financial statements and the election of directors. Registered shareholders who cannot attend are encouraged to submit their proxies by the stated deadline to ensure their votes are counted.
Read more →-OGI
Mar 3, 2025Filed by newsfilecorp.com Organigram Closes Third Tranche of Previously Announced BAT Private Placement Investment
Organigram Holdings Inc. has announced the closing of the third and final tranche of a strategic C$124.56 million equity investment from BT DE Investments, a subsidiary of British American Tobacco. The transaction, closed on February 28, 2025, involved acquiring additional common and preferred shares, boosting Organigram's resources to approximately C$57.8 million for future investments. The funds will primarily support the Jupiter strategic investment pool, targeting international growth opportunities in the cannabis sector.
Read more →-OGI
Dec 6, 2024Filed by newsfilecorp.com FORM 51-102F3 MATERIAL CHANGE REPORT ITEM 1 - Name and Address of Company Organigram Holdings Inc. (the " Company ") 145 King Street West, Suite 1400 Toronto, ON, M5H 1J8 ITEM 2 - Date of Materi
Organigram Holdings Inc. has successfully acquired all outstanding shares of Motif Labs Ltd., making it the largest cannabis company in Canada by market share. The deal, announced on December 6, 2024, for $90 million includes a mix of cash and shares, with additional contingent payments based on future share performance. This acquisition is expected to strengthen Organigram's market position across multiple categories while achieving significant cost synergies and expanding their product portfolio. The move highlights a strategic effort to leverage Motif's existing strengths and distribution capabilities in the rapidly growing cannabis market.
Read more →-OGI
Apr 16, 2024Document NOTICE OF CHANGE OF AUDITOR (National Instrument 51-102) TO KPMG LLP AND TO Ontario Securities Commission New Brunswick Financial and Consumer Services Commission British Columbia Securities Commission Alberta S
Organigram Holdings Inc. announced a change of auditor, with KPMG LLP opting not to stand for reappointment for the 2025 Fiscal Year. This decision is due to KPMG's policy to cease providing audit services to cannabis companies. Despite this, KPMG will assist with interim reviews and the fiscal year-end audit. The company's Board of Directors was not involved in KPMG's decision, and recent audits revealed material weaknesses in internal controls. A notification letter from KPMG will be filed with regulatory authorities.
Read more →-OGI
Apr 2, 2024Filed by newsfilecorp.com FORM 51-102F3 MATERIAL CHANGE REPORT Item One - Name and Address of Company Organigram Holdings Inc. (the " Company ") 145 King Street West, Suite 1400 Toronto, ON, M5H 1J8 Item Two - Date of Ma
Organigram Holdings Inc. announced a successful public offering of units, raising approximately C$28.75 million. The Offering, which included an over-allotment option, attracted interest from underwriters and reflects the company's confidence in its growth initiatives. The net proceeds from the Offering are expected to be used for corporate purposes and to pursue accretive acquisitions in the cannabis market. However, completion of the Offering remains subject to market conditions and regulatory approvals, introducing a level of uncertainty.
Read more →-OGI
Apr 2, 2024Filed by newsfilecorp.com Execution Version [Certain portions of this exhibit have been redacted as they are both not material and are of the type of information that the Company treats as private or confidential. The Co
Organigram Holdings Inc. has entered into an arrangement regarding the issue of warrants as part of an offering of units. The company will sell 8,901,000 units, each comprising one common share and one-half of one warrant. The warrants, which are governed by a Warrant Indenture, will provide holders the right to acquire common shares upon payment of the exercise price before a specified expiration time. The effective registration statement for this transaction is in place under the U.S. Securities Act.
Read more →-OGI
Apr 2, 2024Filed by newsfilecorp.com Organigram Successfully Closes Previously Announced Underwritten Public Offering Including over-allotment Company raises C$28.8 million in gross proceeds improving already strong balance sheet T
Organigram Holdings Inc. has successfully closed its previously announced underwritten public offering, raising approximately C$28.8 million in gross proceeds. The offering included 8,901,000 units priced at C$3.23 each, with a portion sold due to the exercise of the underwriters' over-allotment option. The company intends to utilize these funds for growth initiatives and general corporate purposes. The offering also involved the filing of a prospectus supplement with Canadian and U.S. securities regulators, ensuring compliance with regulatory requirements.
Read more →-OGI
Mar 27, 2024Filed by newsfilecorp.com [Certain portions of this exhibit have been redacted as they are both not material and are of the type of information that the Company treats as private or confidential. The Company agrees to fu
Organigram Holdings Inc. has entered into an underwriting agreement with ATB Securities Inc. and A.G.P. Canada Investments ULC for the sale of 7,740,000 units at a price of $3.23 per unit. The offering is expected to yield gross proceeds of approximately $25 million for the company. Each unit consists of one common share and one-half of a common share purchase warrant. The agreement includes an option for the underwriters to purchase additional units to cover over-allotments.
Read more →-OGI
Mar 27, 2024Filed by newsfilecorp.com Organigram Announces Pricing of Overnight Marketed Public Offering TORONTO--(BUSINESS WIRE)
Organigram Holdings Inc. has announced the pricing of its overnight marketed public offering, aiming to sell 7,740,000 units at C$3.23 each, which is expected to generate about C$25 million. The offering includes an over-allotment option for underwriters to purchase up to an additional 1,161,000 units within 30 days post-closing. Proceeds will be utilized for growth initiatives and general corporate purposes. The offering is anticipated to close around April 2, 2024, pending regulatory approvals.
Read more →-OGI
Mar 26, 2024Filed by newsfilecorp.com Organigram Announces Launch of Overnight Marketed Public Offering TORONTO--(BUSINESS WIRE)
Organigram Holdings Inc. announced the launch of an overnight marketed public offering of units expected to yield about C$25 million. The offering will consist of common shares and warrants, and is to be underwritten by ATB Securities Inc. and affiliates. Proceeds from this offering are intended to support growth initiatives and strategic acquisitions in the cannabis markets. The closing is anticipated on April 2, 2024, subject to regulatory approvals and market conditions.
Read more →-OGI
Feb 13, 2024Document Form 52-109F2 Certification of Interim Filings Full Certificate I, Beena Goldenberg , Chief Executive Officer of Organigram Holdings Inc., certify the following 1. Review I have reviewed the interim financial re
Beena Goldenberg, CEO of Organigram Holdings Inc., has certified the company's interim financial report for the period ending December 31, 2023. She confirmed that the report does not contain any material misrepresentations and that it fairly presents the issuer's financial status. Furthermore, she highlighted the company's established disclosure controls and procedures, which ensure reliable financial reporting. No weaknesses were reported in the internal control framework in relation to the interim filings.
Read more →-OGI
Feb 7, 2024Organigram to Report First Quarter Fiscal 2024 Results on
Organigram Holdings Inc. has announced it will report its first-quarter fiscal 2024 results on February 13, 2024. The reporting period ended on December 31, 2023. A conference call will be held at 8:00 am Eastern Time on that date to discuss the results. Investors can register for the call and a replay will be available shortly after the event.
Read more →-OGI
Jan 31, 2024Organigram Completes First Shipment to Germany, Extending its International Reach TORONTO--(BUSINESS WIRE)
Organigram Holdings Inc. has successfully completed its inaugural shipment of bulk dried flower to Germany, partnering with local company Sanity Group. This shipment is part of a multi-year agreement, allowing Organigram to provide exclusive strains and expand its international reach. The shipment features the Super G Citra strain, known for its appealing aroma and flavor profile. This development marks a significant step for Organigram in tapping into one of the world's largest medical cannabis markets.
Read more →-OGI
Jan 24, 2024Organigram Announces the First Tranche Closing from BAT Investment TORONTO--(BUSINESS WIRE)
Organigram Holdings Inc. has completed the first tranche of its C$124.6 million strategic equity investment from British American Tobacco. The investor acquired nearly 12.9 million common shares, providing significant capital to support Organigram's expansion plans. The completed transaction emphasizes Organigram's ambition to target global markets and invest in emerging cannabis opportunities through its new strategic investment pool, Jupiter. The remaining shares will be issued in two additional tranches by February 2025, enhancing the company's growth strategy.
Read more →-OGI
Jan 23, 2024Filed by newsfilecorp.com AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT between BT DE INVESTMENTS INC. and
Organigram Holdings Inc. and BT DE Investments Inc. have amended and restated their investor rights agreement, effective January 23, 2024. This agreement allows BT DE Investments to subscribe for an additional 38,679,525 common shares and potentially convertible preferred shares for a total investment of approximately $124.56 million. The arrangement is structured in three tranches, and it includes several provisions aimed at enhancing governance and shareholder protections.
Read more →-OGI
Jan 19, 2024Organigram Announces Appointment of Karina Gehring to Board of Directors TORONTO--(BUSINESS WIRE)
Organigram Holdings Inc. announced the appointment of Karina Gehring to its Board of Directors during the annual general meeting held on January 18, 2024. With over 25 years of experience in marketing and brand management at British American Tobacco, her expertise is expected to be a substantial asset to the Board. Gehring's past work includes executing portfolio brand repositioning and enhancing consumer insights, which aligns with Organigram's goals in the cannabis industry.
Read more →-OGI
Jan 18, 2024Organigram Announces Results of Annual and Special Meeting, including Shareholder Approval of C$124.6 Million Investment from BAT TORONTO, Ontario (BUSINESS WIRE)
Organigram Holdings Inc. announced the results of its annual and special meeting, where shareholders approved a significant C$124.6 million investment from British American Tobacco. The meeting also confirmed the election of all nine nominees to the company's board of directors, showcasing strong investor confidence. Additionally, the board approved changes to the company's articles to create a new class of preferred shares as part of the investment agreement. These developments indicate a positive outlook for Organigram as it continues its growth in the cannabis market.
Read more →-OGI
Dec 29, 2023Organigram Announces Mailing of Management Information Circular in Connection with Annual General and Special Meeting Special Meeting to Approve $124.6 Million Investment from BAT at $3.2203/share and Creation of "Jupite
Organigram Holdings Inc. has mailed its management information circular ahead of its annual general and special meeting scheduled for January 18, 2024. The meeting will seek shareholder approval for a strategic equity investment of C$124.6 million from BAT, a subsidiary of British American Tobacco. This investment is intended to facilitate the creation of the 'Jupiter Pool,' aimed at fostering growth and innovation in cannabis products. However, the transaction is contingent on shareholder consent, which introduces an element of uncertainty.
Read more →-OGI
Dec 27, 2023NOTICE OF ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS to be held on
Organigram Holdings Inc. will hold its annual general and special meeting on January 18, 2024, to discuss important business matters, including a significant investment from BT DE Investments Inc. The investment will enable Organigram to explore new cannabis opportunities and enhance its market presence. However, shareholders are advised of certain risks, including potential dilution of shares and the investment being contingent on regulatory approvals. Shareholders will also review governance practices and director nominations during the meeting.
Read more →-OGI
Dec 18, 2023Organigram Announces Appointment of Greg Guyatt as Chief Financial Officer TORONTO--(BUSINESS WIRE)
Organigram Holdings Inc. has appointed Greg Guyatt as Chief Financial Officer, effective January 8, 2024. Guyatt, formerly of Phoena Holdings Inc., will oversee Organigram's Finance and IT divisions, reporting directly to CEO Beena Goldenberg. His extensive experience is expected to support the company's growth ambitions. He replaces Paolo De Luca, who took on the interim CFO role after the departure of Derrick West.
Read more →-OGI
Dec 14, 2023Organigram to Report Fourth Quarter and Fiscal 2023 Results on
Organigram Holdings Inc. announced that it will report its earnings for the fourth quarter and fiscal 2023 on December 19, 2023, prior to market opening. The reported results will cover the quarter ending September 30, 2023. To discuss the results, the company will host a conference call at 8:00 am ET on the same day, with an invitation for participants to register in advance. The company is recognized for producing high-quality cannabis and has a range of brands under its portfolio.
Read more →-OGI
Dec 13, 2023Organigram Wins KIND Magazine's Innovation of the Year for SHRED X Rip-Strips Hash Organigram wins "Innovation of the Year" two years in a row cementing its reputation as a disruptive leader in the cannabis sector TORONT
Organigram Holdings Inc. has been awarded KIND Magazine's 'Innovation of the Year' for its SHRED X Rip-Strips Hash, marking the second consecutive win for the company. This achievement underscores Organigram's role as a disruptive leader in the cannabis industry, as noted by CEO Beena Goldenberg. The company also received nominations in four additional categories at the award event, further highlighting its innovative spirit and product portfolio. Organigram aims to continue its growth and innovation in 2024.
Read more →-OGI
Nov 28, 2023Organigram Increases Investment in Phylos After Successful Milestone Achievement Organigram to advance the conversion of its grow rooms with custom designed, F1 Hybrid seeds Organigram expects to soon be able to begin lo
Organigram Holdings Inc. has increased its investment in Phylos Bioscience after Phylos achieved a key milestone under their loan agreement. The company is converting over 30% of its cultivation space in Moncton to utilize F1 Hybrid seeds, allowing for the production of high-potency, terpene-rich cannabis. This shift aims to streamline operations and reduce costs by eliminating intermediary steps in cultivation. Ongoing trials of Phylos technology have produced uniformly fast-growing seedlings, indicating strong progress in the partnership.
Read more →-OGI
Nov 10, 2023Organigram Announces Interim Chief Financial Officer TORONTO--(BUSINESS WIRE)
Organigram Holdings Inc. has announced that Derrick West will transition away from his role as Chief Financial Officer to focus on health recovery following surgery. In his place, Paolo De Luca, who previously served as CFO from 2017 to 2020, has been appointed as interim CFO effective November 13, 2023. The Board has expressed gratitude for West's contributions during his tenure, noting his role in stabilizing financial processes and supporting company growth. The company is currently searching for a permanent CFO to fill the position long-term.
Read more →-OGI
Nov 6, 2023Organigram Announces C$124.6 Million Investment from BAT and Creation of "Jupiter" Strategic Investment Pool Organigram and BAT deepen partnership through C$124.6 million investment with 38.7 million shares to be issued
Organigram has announced a significant C$124.6 million investment from BAT, which will involve the issuance of 38.7 million shares. The majority of this investment will be allocated to the creation of the "Jupiter" strategic investment pool aimed at expanding Organigram's geographic reach and supporting product development initiatives. The investment is expected to strengthen Organigram's financial position and enhance its capabilities in a rapidly evolving cannabis market. This partnership reinforces the ongoing collaboration for innovative product development between Organigram and BAT.
Read more →-OGI
Nov 5, 2023FORM 51-102F3 MATERIAL CHANGE REPORT Item One - Name and Address of Company Organigram Holdings Inc. (the " Company ") 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 Item Two - Date of Material Change
Organigram Holdings Inc. announced a proposed private placement worth C$124,559,674.36 with a subsidiary of British American Tobacco. This investment will occur in three tranches, with the first expected to close around January 16, 2024, subject to certain conditions. The funds are aimed at enhancing the company's agility and investment capacity within the cannabis sector through a new strategic investment pool called Jupiter. Approval from shareholders and regulatory bodies, as well as some amendments to corporate articles, are required to proceed.
Read more →-OGI
Nov 5, 2023Filed by newsfilecorp.com SUBSCRIPTION AGREEMENT between BT DE INVESTMENTS INC. and
Organigram Holdings Inc. and BT DE Investments Inc. have entered into a Subscription Agreement for the sale of shares. This agreement, dated November 5, 2023, includes the issuance of a total of 38,679,525 subscription shares, structured over three tranches. The total investment amounts to approximately $124.6 million, showcasing a notable capital transaction for Organigram Holdings as part of its future financial strategy.
Read more →-OGI
Oct 18, 2023Organigram Provides Corporate Update Achieves #2 Market Share Over the Last Two Months TORONTO--(BUSINESS WIRE)
Organigram Holdings Inc. has announced that it has secured the #2 market share position in the Canadian cannabis market, driven primarily by a strong performance in its pre-roll and gummies segments. The company attributes its success to innovative product developments and strategic acquisitions. Additionally, Organigram is expanding its product offerings and reducing its environmental footprint through energy-efficient practices. The company is also preparing for future product launches and collaborations to enhance its market presence further.
Read more →-OGI
Oct 11, 2023Organigram Holdings Inc. Files Final Base Shelf Prospectus TORONTO--(BUSINESS WIRE)
Organigram Holdings Inc. has filed a final base shelf prospectus, allowing the company to qualify the distribution of up to C$500 million in securities over a 25-month period. This filing is intended to provide financing flexibility as the company pursues its objectives. The registration statement for the U.S. Securities and Exchange Commission is pending effectiveness. Additionally, although the prospectus opens avenues for future financing, there are inherent risks that may impact the realization of these opportunities.
Read more →-OGI
Sep 25, 2023Organigram Holdings Inc. Files Preliminary Base Shelf Prospectus TORONTO--(BUSINESS WIRE)
Organigram Holdings Inc. has filed a preliminary base shelf prospectus with Canadian securities regulators and a corresponding shelf registration statement with the U.S. SEC. This prospectus, once effective, will enable Organigram to offer up to C$500 million in various securities, providing the company with flexible financing options. This move reflects the company's strategic approach to further its objectives and enhance its position in the cannabis industry.
Read more →-OGI
Sep 1, 2023Organigram Announces Resignation of Board Member TORONTO--(BUSINESS WIRE)
Organigram Holdings Inc. announced the resignation of board member Ms. Caroline Ferland, effective immediately. Ferland, who was appointed by British American Tobacco (BAT), contributed significantly to the company's strategic planning and governance during her tenure. She has left to take on a new role as Group Company Secretary & Assistant General Counsel for BAT in the UK. The Board thanked her for her contributions and anticipates that BAT will nominate a replacement soon.
Read more →-OGI
Aug 28, 2023Organigram Launches First Range of THCV Products Derived from Moncton-Grown Whole Flower First lineup of THCV products enabled by Organigram's strategic investment in Phylos Bioscience TORONTO--(BUSINESS WIRE)
Organigram Holdings Inc. has announced the launch of its first range of whole-flower derived THCV products, which are supported by a strategic investment in Phylos Bioscience. This new lineup is a significant addition to their SHRED and Trailblazer brands and aims to satisfy consumer demand for innovative cannabis products. Organigram is reportedly the only licensed Canadian producer to cultivate and extract THCV in-house. The company has exclusive rights to unique high-THCV cultivars, promising a differentiated user experience in the cannabis market.
Read more →-OGI
Aug 21, 2023Organigram Relaunches one of Canada's First Cannabis Brands, Trailblazer Trailblazer returns to the Canadian marketplace with a new range of products TORONTO--(BUSINESS WIRE)
Organigram Holdings Inc. has announced the relaunch of its cannabis brand, Trailblazer, in Canada. This initiative includes a modernized brand identity and a new product lineup designed to meet the needs of consumers prioritizing whole-plant wellness. The initial offerings will include unique products like THCV gummies and high-potency pre-rolls. This relaunch aims to connect with a significant market segment and expand Organigram's presence in the cannabis industry.
Read more →-OGI
Aug 15, 2023Organigram to Enter the United Kingdom with Agreement to Supply Medical Cannabis to 4C LABS Organigram to supply 4C LABS with high-quality Medical Cannabis for distribution to UK Medical Cannabis patients Organigram chos
Organigram has entered into a supply agreement with 4C LABS to provide medical cannabis to the United Kingdom. The agreement will see approximately 600 kilograms of high-quality product supplied within the first year, with potential for increased targets thereafter. This partnership is part of Organigram's strategy to expand its global presence, having already established agreements in other international markets such as Israel and Australia. The collaboration aims to improve access to medical cannabis for patients in the UK, addressing a market with limited local options.
Read more →-OGI
Aug 10, 2023Organigram's Application for Judicial Review on Jolts Ingestible Extract Granted TORONTO--(BUSINESS WIRE)
Organigram Holdings Inc. has received a favorable ruling from the Federal Court of Canada regarding its application for a judicial review of Health Canada's classification of Edison Jolts lozenges. The Court determined that there was a breach of procedural fairness by Health Canada and has referred the matter back for re-evaluation. This outcome is seen as a significant development for Organigram as it seeks to have its products reclassified appropriately within the cannabis regulations. The CEO expressed confidence in the review process and the importance of accurate regulatory classification for the cannabis sector.
Read more →-OGI
Aug 2, 2023Organigram Launches New Tube-style Pre-rolls: SHRED Dartz and Holy Smokes Both SHRED Dartz and Holy Smokes come in 10x0.4g packs and are rolled with 100% organic hemp paper providing a more natural and elevated cannabis
Organigram Holdings Inc. has announced the launch of its new tube-style pre-rolls, SHRED Dartz and Holy Smokes, which come in 10x0.4g packs. These products use 100% organic hemp paper, reflecting a commitment to quality and consumer preference. The introduction is timely, anticipating ongoing demand growth, especially in Ontario where tube-style pre-rolls have seen significant sales increases. The company aims to capture a larger share of this expanding market segment with its unique offerings tailored to consumer tastes.
Read more →-OGI
Jul 13, 2023Organigram to Report Third Quarter Fiscal 2023 Results on
Organigram Holdings Inc. will report its financial results for the third quarter of fiscal 2023 on July 13, 2023, after market close. Following the earnings release, the company will host a conference call on July 14, 2023, at 8:00 am Eastern Time. Investors and stakeholders can register for the call and will have access to a replay of the webcast within 24 hours. Organigram aims to maintain transparency and keep its audience informed about its operational performance.
Read more →-OGI
Jul 5, 2023Filed by newsfilecorp.com Organigram Announces Completion of Share Consolidation TORONTO--(BUSINESS WIRE)
Organigram Holdings Inc. has announced the successful completion of its share consolidation, implementing a ratio of four pre-consolidation shares for each post-consolidation share. Following this consolidation, approximately 80.5 million common shares will be outstanding, down from nearly 322 million. This action is aimed at restoring compliance with Nasdaq's continued listing requirements after the company's share price dipped below $1.00. The post-consolidation shares are expected to begin trading under a new CUSIP number on July 7, 2023.
Read more →-OGI
Jun 21, 2023Organigram Introduces Ultra High-THC Infused Pre-Rolls, SHRED X Heavies SHRED X Heavies is one of the only infused pre-roll offerings to combine diamonds, distillate, and botanical terpenes, providing an unparalleled exp
Organigram Holdings Inc. has launched SHRED X Heavies, a new line of ultra high-THC infused pre-rolls. These products combine diamonds, distillate, and botanical terpenes, achieving a potency exceeding 40%. Available in popular flavors, each package contains three 0.5g pre-rolls. This launch aligns with consumer trends showing growing demand for infused pre-rolls, as they accounted for a significant portion of pre-roll sales in early 2023.
Read more →-OGI
Jun 19, 2023Organigram Announces Effective Date of Share Consolidation TORONTO--(BUSINESS WIRE)
Organigram Holdings Inc. announced the effective date for its share consolidation, which is set to take place on July 5, 2023. This consolidation involves a ratio of four pre-consolidation common shares for every post-consolidation common share and aims to comply with Nasdaq listing requirements. The announcement indicates that the company seeks to enhance the marketability of its common shares to institutional investors while reducing stock price volatility. This process will be automatic for shareholders, who will not need to take any action, and trading will resume under the same ticker symbols.
Read more →-OGI
May 25, 2023Organigram Makes First Strategic U.S. Investment in Phylos Bioscience to Commercialize THCV and Scale Seed Based Production Phylos is a recognized leader in seed genetics with a growing IP portfolio including the highest
Organigram Holdings Inc. has announced its first strategic investment in Phylos Bioscience to commercialize THCV and enhance seed-based cannabis production. This collaboration aims to develop high potency, whole plant-derived THCV products, such as vapes and gummies, for the Canadian market. Phylos will provide production-ready F1 hybrid cannabis seeds to facilitate efficient cultivation and product development. The investment is expected to reduce operating costs and create a pathway for future international market expansions.
Read more →-OGI
May 23, 2023Organigram to Enter German Market Supplying Sanity Group Organigram to supply the medical division of German cannabis company Sanity Group with high-quality medical flower for distribution in Germany. Germany is expected
Organigram has announced a supply agreement with Sanity Group, a German cannabis company, to provide high-quality medical flower. This collaboration allows Organigram to extend its international footprint, adding Germany to its list of markets where it services medical patients. With Germany potentially legalizing recreational cannabis, this partnership positions Organigram favorably in a rapidly evolving market. The agreement includes exclusivity on certain cannabis strains for Sanity Group, emphasizing a strategic alignment between the two companies.
Read more →-OGI
May 19, 2023Organigram Announces Achievement of Earnout by The Edibles and Infusions Corporation TORONTO--(BUSINESS WIRE)
Organigram Holdings Inc. announced that its subsidiary, The Edibles and Infusions Corporation (EIC), has met key earnout milestones related to their acquisition in April 2021. The company issued 7,943,107 common shares worth $5 million for the achievement of the second milestone, bringing the total earnout consideration to $8.5 million. An additional $2 million in shares may be issued depending on outstanding contractual matters. This reinforces Organigram's commitment to expanding its cannabis product offerings in the evolving market.
Read more →-OGI
May 15, 2023NOTICE OF CHANGE IN YEAR-END PURSUANT TO SECTION 4.8 OF NATIONAL INSTRUMENT 51-102 ORGANIGRAM HOLDINGS INC. 1. Change in Financial Year-End Notice is hereby provided pursuant to section 4.8 of National Instrument 51-102
Organigram Holdings Inc. has announced a change in its financial year-end from August 31 to September 30. This shift is intended to better align the company's financial reporting with other public companies and standard calendar quarters. The change is expected to enhance the comparability and transparency of the company's financial statements.
Read more →-OGI
Apr 4, 2023Organigram to Report Second Quarter Fiscal 2023 Results on
Organigram Holdings Inc. announced that it will report its second quarter fiscal 2023 results on April 11, 2023. The results, covering the period ended February 28, 2023, will be followed by a conference call scheduled for April 12, 2023, at 8:00 am Eastern Time. This conference call will allow for discussion of the results with stakeholders and interested parties.
Read more →-OGI
Mar 31, 2023Organigram Accelerates Focus on Vapes With Strategic Investment in Greentank Organigram's deal with Greentank which brings new heating technology is anticipated to grow Organigram's vape market position with plans to lau
Organigram Holdings Inc. has announced a strategic investment in Greentank to enhance its vape market position. The deal includes an 18-month exclusivity period for new heating technology in Canada for 510 vape cartridges. Organigram's $4 million USD investment is expected to transform its vapour hardware lineup while demonstrating its commitment to innovation in the cannabis market. The latest technology aims to provide improved consumer experiences through enhanced performance and flavor delivery.
Read more →-OGI
Mar 21, 2023Organigram Announces Director Appointment TORONTO--(BUSINESS WIRE)
Organigram Holdings Inc. has appointed Caroline Ferland to its Board of Directors, designated by BAT. Ferland brings significant legal and regulatory experience, enhancing the board's capabilities. Her background includes leadership roles in compliance at BAT and other organizations, making her a valuable addition to the team. This appointment increases the board's total number of directors to ten, reflecting the company's commitment to strong governance.
Read more →-OGI
Mar 13, 2023Organigram Provides Edison JOLTS Product Update TORONTO--(BUSINESS WIRE)
Organigram Holdings Inc. has been notified by Health Canada that some of its Edison Jolts lozenge products, specifically those containing 100 mg THC, have been misclassified as extracts instead of edibles. The company maintains that these products comply with cannabis regulations and plans to consult legal advisors on the issue. In light of the notification, Organigram has paused production of the affected products while they assess their options. They are permitted to continue selling existing inventory until May 31, 2023.
Read more →-OGI
Feb 28, 2023Organigram Holdings Inc. Announces Election of Directors TORONTO, Ontario (BUSINESS WIRE)
Organigram Holdings Inc. held its annual general and special meeting of shareholders on February 28, 2023, where all nine nominees for the board of directors were elected. The votes for each nominee showed a strong majority, with percentages of votes for each exceeding 87%. This election reflects the shareholders' confidence in the management and direction of Organigram, which operates in the Canadian cannabis market.
Read more →-OGI
Feb 27, 2023Organigram Revolutionizes Hash with SHRED X Rip-Strip Hash SHRED aims to introduce hash to a new generation of consumers with 10 pre-cut, botanical terpene-infused hash Rip Strips TORONTO--(BUSINESS WIRE)
Organigram Holdings Inc. has launched SHRED X Rip-Strip Hash, an innovative product aimed at modern cannabis consumers. This product features 10 pre-cut, botanical terpene-infused strips, making hash more accessible and user-friendly. Targeting both inexperienced consumers and existing hash users, the new format is designed to enhance convenience and flavor. Organigram continues to maintain a leading position in the Canadian cannabis hash market, expanding its popular SHRED product line.
Read more →-OGI
Jan 26, 2023Organigram Provides NASDAQ Listing Update TORONTO--(BUSINESS WIRE)
Organigram Holdings Inc. announced that it has been notified by NASDAQ of its non-compliance with the minimum bid price requirement, as its common shares have closed below $1.00 for 30 consecutive trading days. The company has a period of 180 days to regain compliance, with the deadline set for July 24, 2023. If it fails to meet this requirement within the specified time, Organigram may face delisting from NASDAQ, although its status on the Toronto Stock Exchange remains unaffected. The company is actively working to stabilize its stock price and maintain its listing status.
Read more →-OGI
Jan 12, 2023CERTIFICATION Form 52-109F2 Certification of Interim Filings Full Certificate I, Beena Goldenberg , Chief Executive Officer of Organigram Holdings Inc., certify the following 1. Review I have reviewed the interim financi
Beena Goldenberg, CEO of Organigram Holdings Inc., has certified the company's interim financial filings for the period ending November 30, 2022. She affirmed that these reports do not contain any material misrepresentations and that they accurately reflect the financial condition and performance of the company. The certification underscores the company's commitment to transparency and compliance with financial reporting standards. Additionally, the internal controls over financial reporting have been established and are actively monitored.
Read more →-OGI
Jan 5, 2023Organigram to Report First Quarter Fiscal 2023 Results on
Organigram Holdings Inc. will report its first quarter fiscal 2023 earnings results on January 12, 2023. The announcement includes details about a conference call scheduled for the same day to discuss the results. Organigram is focusing on maintaining its status as a leading cannabis producer and expanding its international partnerships. The company is subject to various regulatory and market factors that could influence its performance.
Read more →-OGI
Dec 19, 2022Filed by newsfilecorp.com
To: The United States Securities and Exchange Commission Organigram Holdings Inc. (the "Company") We refer to the Company's registration statement on Form F-10 (File No. 333-257363), filed June 24, 2021, and the Amendment No. 1 thereto, filed August 31, 2021, as the same may he
Read more →-OGI
Dec 8, 2022Organigram Wins KIND Magazine's Cannabis Company of the Year Award and Most Innovative Product of the Year for Edison JOLTS TORONTO--(BUSINESS WIRE)
Organigram Wins KIND Magazine's Cannabis Company of the Year Award and Most Innovative Product of the Year for Edison JOLTS TORONTO--(BUSINESS WIRE)--December 8, 2022--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of a leading licensed producer of cannabi
Read more →-OGI
Nov 23, 2022Organigram Launches HOLY MOUNTAIN to Further Support Its Strong Position in the Dried Flower and Hash Categories HOLY MOUNTAIN product portfolio will primarily focus on value whole flower and concentrates TORONTO--(BUSIN
Organigram Launches HOLY MOUNTAIN to Further Support Its Strong Position in the Dried Flower and Hash Categories HOLY MOUNTAIN product portfolio will primarily focus on value whole flower and concentrates TORONTO--(BUSINESS WIRE)--November 23, 2022--Organigram Holdings Inc. (NA
Read more →-OGI
Nov 18, 2022Organigram to Report Annual Fiscal 2022 Results on
Organigram to Report Annual Fiscal 2022 Results on November 28, 2022 TORONTO--(BUSINESS WIRE)--November 17, 2022--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the "Company" or "Organigram"), a leading licensed producer of ca
Read more →-OGI
Nov 17, 2022Organigram and InterCure (dba : Canndoc) Sign New International Strategic Agreement Representing Largest Such Deal to Date for Both Companies Organigram to supply Israeli pharmaceutical grade cannabis leader InterCure wi
Organigram and InterCure (dba : Canndoc) Sign New International Strategic Agreement Representing Largest Such Deal to Date for Both Companies Organigram to supply Israeli pharmaceutical grade cannabis leader InterCure with up to 20,000 kg of dried flower over multiple years TOR
Read more →-OGI
Jul 14, 2022Organigram to Report Third Quarter 2022 Results on
Organigram to Report Third Quarter 2022 Results on July 14, 2022 TORONTO--(BUSINESS WIRE)--July 8, 2022--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the "Company" or "Organigram"), a leading licensed producer of cannabis, a
Read more →-OGI
Jul 13, 2022Filed by newsfilecorp.com INTRODUCTION This Management's Discussion and Analysis dated
This Management's Discussion and Analysis dated July 13, 2022 (this "MD&A"), should be read in conjunction with the condensed consolidated interim financial statements (the "Interim Financial Statements") of Organigram Holdings Inc. (the "Company" or "Organigram") for the three a
Read more →-OGI
Jun 23, 2022Proposed Settlement Reached in 2016 Class Action TORONTO--(BUSINESS WIRE)
Proposed Settlement Reached in 2016 Class Action TORONTO--(BUSINESS WIRE)--June 23, 2022--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), and its subsidiary Organigram Inc. (together, the "Company" or "Organigram"), a leading licensed producer of cannabis in Canada, has reach
Read more →-OGI
Apr 1, 2022Organigram to Report Second Quarter 2022 Results on
Organigram to Report Second Quarter 2022 Results on April 12, 2022 TORONTO--(BUSINESS WIRE)--April 1, 2022--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the "Company" or "Organigram"), a leading licensed producer of cannabis
Read more →-OGI
Mar 24, 2022Organigram Provides Corporate Update and Announces New Product Launches TORONTO--(BUSINESS WIRE)
Organigram Provides Corporate Update and Announces New Product Launches TORONTO--(BUSINESS WIRE)--March 24, 2022--Organigram Holdings Inc. (TSX: OGI and NASDAQ: OGI), the parent company of Organigram Inc. (collectively "Organigram" or the "Company"), a leading licensed producer
Read more →-OGI
Mar 17, 2022Organigram Joins the Pledge 1% Movement Launches its Social Impact Strategy Organigram Operating for Good' TORONTO--(BUSINESS WIRE)
Organigram Joins the Pledge 1% Movement Launches its Social Impact Strategy Organigram Operating for Good' TORONTO--(BUSINESS WIRE)--March 17, 2022--Organigram Holdings Inc. (TSX: OGI and NASDAQ: OGI), the parent company of Organigram Inc. (collectively "Organigram" or the "Com
Read more →-OGI
Feb 28, 2022BAT Exercises Top-Up Rights to Invest $6.3 Million Resulting in an Increase in Equity Position from 18.8% to 19.5% MONCTON, New Brunswick--(BUSINESS WIRE)
BAT Exercises Top-Up Rights to Invest $6.3 Million Resulting in an Increase in Equity Position from 18.8% to 19.5% MONCTON, New Brunswick--(BUSINESS WIRE)--February 28, 2022--Organigram Holdings Inc. (TSX: OGI and NASDAQ: OGI), the parent company of Organigram Inc. (collectively
Read more →-OGI
Feb 23, 2022Organigram Holdings Inc. Announces Election of Directors BAT s Simon Ashton Appointed to the Board of Directors MONCTON, New Brunswick (BUSINESS WIRE)
Organigram Holdings Inc. Announces Election of Directors BAT s Simon Ashton Appointed to the Board of Directors MONCTON, New Brunswick (BUSINESS WIRE) February 23, 2022 Organigram Holdings Inc. ( Organigram or the Corporation ) (TSX: OGI) (NASDAQ: OGI) announced today the resu
Read more →-OGI
Feb 2, 2022NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS to be held on
NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS to be held on February 23, 2022 INFORMATION CIRCULAR Dated: January 18, 2022 NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS to be held on February 23, 2022 NOTICE IS HEREBY GIVEN that an annual general meeting (the Meeting
Read more →-OGI
Jan 5, 2022Organigram to Report First Quarter Fiscal 2022 Results on
Organigram to Report First Quarter Fiscal 2022 Results on January 11, 2022 MONCTON, New Brunswick--(BUSINESS WIRE)--January 5, 2022--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the "Company" or "Organigram"), a leading lice
Read more →-OGI
Dec 22, 2021Organigram Makes Additional $2.5 Million Investment in Hyasynth Biologicals, a Leading Cannabinoid Biosynthesis Company With growing interest in sustainable and bio-based cannabinoids, and after completing a strategic re
Organigram Makes Additional $2.5 Million Investment in Hyasynth Biologicals, a Leading Cannabinoid Biosynthesis Company With growing interest in sustainable and bio-based cannabinoids, and after completing a strategic review of Hyasynth including their intellectual property (IP)
Read more →-OGI
Dec 21, 2021Filed by newsfilecorp.com FORM 51-102F3 MATERIAL CHANGE REPORT Item One - Name and Address of Company Organigram Holdings Inc. (the " Company ") 35 English Drive Moncton, NB E1E 3X3 Item Two - Date of Material Change
MATERIAL CHANGE REPORT Item One - Name and Address of Company Organigram Holdings Inc. (the "Company") Item Two - Date of Material Change Item Three - News Release The news release reporting the material change described in this report was issued in Moncton, New Brunswick on
Read more →-OGI
Dec 21, 2021Organigram Acquires Quebec-Based Laurentian Organic Inc. in Accretive Transaction Leading premium hash brand, Tremblant Cannabis, and craft brand, Laurentian, complement Organigram's portfolio of consumer-centric brands
Organigram Acquires Quebec-Based Laurentian Organic Inc. in Accretive Transaction Leading premium hash brand, Tremblant Cannabis, and craft brand, Laurentian, complement Organigram's portfolio of consumer-centric brands Strengthens Organigram's position in the second most popul
Read more →-OGI
Nov 18, 2021Organigram Launches New Wellness Brand, Monjour Monjour's CBD-forward product assortment is designed to complement one's daily wellness routine MONCTON, New Brunswick--(BUSINESS WIRE)
Organigram Launches New Wellness Brand, Monjour Monjour's CBD-forward product assortment is designed to complement one's daily wellness routine MONCTON, New Brunswick--(BUSINESS WIRE)--November 18, 2021--Organigram Holdings Inc. ("Organigram" or the "Company") (TSX: OGI) (NASDA
Read more →-OGI
Nov 15, 2021Organigram to Report Fourth Quarter and Full Year Fiscal 2021 Results on
Organigram to Report Fourth Quarter and Full Year Fiscal 2021 Results on November 23, 2021 MONCTON, New Brunswick--(BUSINESS WIRE)--November 15, 2021--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the "Company" or "Organigram
Read more →-OGI
Nov 1, 2021Organigram Provides Corporate Update MONCTON, New Brunswick--(BUSINESS WIRE)
Organigram Provides Corporate Update MONCTON, New Brunswick--(BUSINESS WIRE)--November 1, 2021--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) (the "Company" or "Organigram"), the parent company of Organigram Inc., a leading licensed producer of cannabis, provided a corporate
Read more →-OGI
Aug 31, 2021Organigram Holdings Inc. Files Final Base Shelf Prospectus MONCTON, New Brunswick--(BUSINESS WIRE)
Organigram Holdings Inc. Files Final Base Shelf Prospectus MONCTON, New Brunswick--(BUSINESS WIRE)--August 31, 2021--Organigram Holdings Inc. ("Organigram" or the "Corporation") (TSX: OGI) (NASDAQ: OGI) announced today that it has obtained a receipt for a final short form base s
Read more →-OGI
Aug 25, 2021Organigram Extends Popular SHRED Product Portfolio with High-quality, Value-priced SHRED'ems Gummies Captures #1 share of edibles position in inaugural launch province of PEI within two weeks of launch MONCTON, New Bruns
Organigram Extends Popular SHRED Product Portfolio with High-quality, Value-priced SHRED'ems Gummies Captures #1 share of edibles position in inaugural launch province of PEI within two weeks of launch MONCTON, New Brunswick--(BUSINESS WIRE)--August 25, 2021--Organigram Holding
Read more →-OGI
Aug 17, 2021Organigram Launches Edison JOLTS, Reinvents the Ingestible Extract A first-to-market product, Edison JOLTS lozenges combine the benefits of sublingual oil with the convenience and portability of softgels MONCTON, New Bru
Organigram Launches Edison JOLTS, Reinvents the Ingestible Extract A first-to-market product, Edison JOLTS lozenges combine the benefits of sublingual oil with the convenience and portability of softgels MONCTON, New Brunswick--(BUSINESS WIRE)--August 17, 2021--Organigram Holdi
Read more →-OGI
Aug 4, 2021Filed by newsfilecorp.com FORM 51-102F3 MATERIAL CHANGE REPORT Item One - Name and Address of Company Organigram Holdings Inc. 35 English Drive Moncton, NB E1E 3X3 Item Two - Date of Material Change
MATERIAL CHANGE REPORT Item One - Name and Address of Company Organigram Holdings Inc. Item Two - Date of Material Change Item Three - News Release The news release reporting the material change described in this report was issued in Moncton, New Brunswick on August 4, 2021
Read more →-OGI
Aug 4, 2021Organigram Appoints Beena Goldenberg as Chief Executive Officer MONCTON, New Brunswick--(BUSINESS WIRE)
Organigram Appoints Beena Goldenberg as Chief Executive Officer MONCTON, New Brunswick--(BUSINESS WIRE)--August 4, 2021--Organigram Holdings Inc. ("Organigram" or the "Company") (TSX: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading Canadian producer of cann
Read more →-OGI
Jul 15, 2021Organigram Launches Cannabis Innovators Panel Panel supports Company's ongoing commitment to consumer-driven product development and innovation MONCTON, New Brunswick--(BUSINESS WIRE)
Organigram Launches Cannabis Innovators Panel Panel supports Company's ongoing commitment to consumer-driven product development and innovation MONCTON, New Brunswick--(BUSINESS WIRE)--July 15, 2021--Organigram Holdings Inc. ("Organigram" or the "Company") (TSX: OGI) (NASDAQ: O
Read more →-OGI
Jul 6, 2021Organigram to Report Third Quarter Fiscal 2021 Results on
Organigram to Report Third Quarter Fiscal 2021 Results on July 13, 2021 MONCTON, New Brunswick--(BUSINESS WIRE)--July 5, 2021--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of
Read more →-OGI
Jun 24, 2021Filed by newsfilecorp.com Organigram Holdings Inc. Files Preliminary Base Shelf Prospectus MONCTON, New Brunswick - (BUSINESS WIRE)
Organigram Holdings Inc. Files Preliminary Base Shelf Prospectus MONCTON, New Brunswick - (BUSINESS WIRE) - June 24, 2021 - Organigram Holdings Inc. ("Organigram" or the "Corporation") (TSX: OGI) (NASDAQ: OGI) announced today that it has a filed a preliminary short form base she
Read more →-OGI
Jun 3, 2021Organigram Recruits for as Many as 75 Roles Based in Moncton, New Brunswick Company hiring for positions including product research and development, production, cultivation and other support roles Recently launched Organ
Organigram Recruits for as Many as 75 Roles Based in Moncton, New Brunswick Company hiring for positions including product research and development, production, cultivation and other support roles Recently launched Organigram/BAT Centre of Excellence, formed to focus on develop
Read more →-OGI
May 31, 2021Organigram Appoints Senior Vice President of Marketing MONCTON, New Brunswick--(BUSINESS WIRE)
Organigram Appoints Senior Vice President of Marketing MONCTON, New Brunswick--(BUSINESS WIRE)--May 31, 2021--Organigram Holdings Inc. ("Organigram" or the "Company") (TSX: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading producer of cannabis, is pleased to a
Read more →-OGI
May 18, 2021Organigram Launches Big Bag o' Buds Indoor-grown, Strain-specific Dried Flower in 28g Value Format Big Bag o' Buds strains include both celebrated and new cultivars, including Organigram's industry-leading Ultra Sour MON
Organigram Launches Big Bag o' Buds Indoor-grown, Strain-specific Dried Flower in 28g Value Format Big Bag o' Buds strains include both celebrated and new cultivars, including Organigram's industry-leading Ultra Sour MONCTON, New Brunswick,--(BUSINESS WIRE)--May 18, 2021--Organ
Read more →-OGI
May 10, 2021Organigram Appoints Vice President of Innovation MONCTON, New Brunswick--(BUSINESS WIRE)
Organigram Appoints Vice President of Innovation MONCTON, New Brunswick--(BUSINESS WIRE)--May 10, 2021--Organigram Holdings Inc. ("Organigram" or the "Company") (TSX: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading producer of cannabis, is pleased to announc
Read more →-OGI
May 3, 2021Organigram CEO Steps Away From Role, Will Continue to Act as a Special Advisor to the Board of Directors; Interim Leadership Appointed MONCTON, New Brunswick--(BUSINESS WIRE)
Organigram CEO Steps Away From Role, Will Continue to Act as a Special Advisor to the Board of Directors; Interim Leadership Appointed MONCTON, New Brunswick--(BUSINESS WIRE)--May 3, 2021--The Board of Directors (the "Board") of Organigram Holdings Inc. ("Organigram" or the "C
Read more →-OGI
Apr 22, 2021Organigram Expands Edison Cannabis Co. Dried Flower Portfolio with Two New High THC Strains: GMO Cookies and MAC-1 MONCTON, New Brunswick--(BUSINESS WIRE)
Organigram Expands Edison Cannabis Co. Dried Flower Portfolio with Two New High THC Strains: GMO Cookies and MAC-1 MONCTON, New Brunswick--(BUSINESS WIRE)--April 22, 2021--As part of the continued expansion of its Edison Cannabis Co. ("Edison") line of products, Organigram Holdi
Read more →-OGI
Apr 6, 2021Organigram Acquires Soft Chew Manufacturer: Edibles & Infusions Corporation, a Cannabis Processor Backed by Decades of Confectionary Experience Positions Organigram to generate significant incremental near-term revenue g
Organigram Acquires Soft Chew Manufacturer: Edibles & Infusions Corporation, a Cannabis Processor Backed by Decades of Confectionary Experience Positions Organigram to generate significant incremental near-term revenue growth from soft chews, the largest edible category Provide
Read more →-OGI
Apr 6, 2021Organigram to Report Second Quarter Fiscal 2021 Results on
Organigram to Report Second Quarter Fiscal 2021 Results on April 13, 2021 MONCTON, New Brunswick--(BUSINESS WIRE)--April 5, 2021--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer
Read more →-OGI
Apr 1, 2021Organigram Repays Credit Facilities with Bank of Montreal In discussions for new revolving facility to maintain financial flexibility MONCTON, New Brunswick--(BUSINESS WIRE)
Organigram Repays Credit Facilities with Bank of Montreal In discussions for new revolving facility to maintain financial flexibility MONCTON, New Brunswick--(BUSINESS WIRE)--April 1, 2021--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc.
Read more →-OGI
Mar 30, 2021Organigram Launches "Indi", an Indica-only Brand, and Three New Edison Indica Pre-rolls: Black Cherry Punch, Ice Cream Cake (I.C.C.) and Slurricane Commitment to cannabis genetic research and development continues to dri
Organigram Launches "Indi", an Indica-only Brand, and Three New Edison Indica Pre-rolls: Black Cherry Punch, Ice Cream Cake (I.C.C.) and Slurricane Commitment to cannabis genetic research and development continues to drive Organigram's product development program MONCTON, New B
Read more →-OGI
Mar 11, 2021Organigram and BAT Form Product Development Collaboration - Includes Strategic Investment from BAT for 19.9% Equity Interest Accelerates Organigram's R&D and product pipeline development, provides meaningful capital inje
Organigram and BAT Form Product Development Collaboration - Includes Strategic Investment from BAT for 19.9% Equity Interest Accelerates Organigram's R&D and product pipeline development, provides meaningful capital injection of ~C$221 million and strengthens Organigram's abilit
Read more →-OGI
Mar 2, 2021Organigram Launches SHRED Tropic Thunder Jar of J's (Jar of Joints) and Trailblazer SNAX Milk Chocolate Bars MONCTON, New Brunswick--(BUSINESS WIRE)
Organigram Launches SHRED Tropic Thunder Jar of J's (Jar of Joints) and Trailblazer SNAX Milk Chocolate Bars MONCTON, New Brunswick--(BUSINESS WIRE)--March 2, 2021--As part of its consumer-first product innovation strategy, Organigram Holdings Inc. ("Organigram" or the "Company"
Read more →-OGI
Feb 23, 2021Filed by newsfilecorp.com Organigram Holdings Inc. Announces Election of Directors MONCTON, New Brunswick - (BUSINESS WIRE)
Organigram Holdings Inc. Announces Election of Directors MONCTON, New Brunswick - (BUSINESS WIRE) - February 23, 2021 - Organigram Holdings Inc. ("Organigram" or the "Corporation") (TSX: OGI) (NASDAQ: OGI) announced today the results of voting at its annual meeting of shareholde
Read more →-OGI
Feb 2, 2021Organigram Announces Executive Changes MONCTON, New Brunswick--(BUSINESS WIRE)
Organigram Announces Executive Changes MONCTON, New Brunswick--(BUSINESS WIRE)--February 2, 2021--Organigram Holdings Inc. ("Organigram" or the "Company") (TSX: OGI) (NASDAQ: OGI) announces Matt Rogers, Senior Vice President, Operations, will be leaving Organigram at the end of
Read more →-OGI
Jan 11, 2021Organigram Appoints Marni Wieshofer to the Board of Directors California-based Former Chief Financial Officer and Executive Vice-President at Lions Gate Entertainment Corporation Represents Organigram's First U.S. Domici
Organigram Appoints Marni Wieshofer to the Board of Directors California-based Former Chief Financial Officer and Executive Vice-President at Lions Gate Entertainment Corporation Represents Organigram's First U.S. Domiciled Director MONCTON, New Brunswick--(BUSINESS WIRE)--Janu
Read more →-OGI
Jan 5, 2021Organigram to Report First Quarter Fiscal 2021 Results on
Organigram to Report First Quarter Fiscal 2021 Results on January 12, 2021 MONCTON, New Brunswick--(BUSINESS WIRE)--January 4, 2021--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed produ
Read more →-OGI
Dec 22, 2020Organigram Expands Edison Portfolio With Three New Indica Genetics - Black Cherry Punch, Ice Cream Cake (I.C.C.), and Slurricane Edison dried flower portfolio continues to thrive with ongoing investment in genetics progr
Organigram Expands Edison Portfolio With Three New Indica Genetics - Black Cherry Punch, Ice Cream Cake (I.C.C.), and Slurricane Edison dried flower portfolio continues to thrive with ongoing investment in genetics program and micro-climate management MONCTON, New Brunswick--(B
Read more →-OGI
Dec 16, 2020Organigram Launches New 1g Trailblazer Torch Vape Cartridges Trailblazer Spark, Flicker and Glow 510-thread vape cartridges now available in both 0.5g and 1g formats Featured flavours include Purple Punch, Maui Wowie and
Organigram Launches New 1g Trailblazer Torch Vape Cartridges Trailblazer Spark, Flicker and Glow 510-thread vape cartridges now available in both 0.5g and 1g formats Featured flavours include Purple Punch, Maui Wowie and Cherry Kush MONCTON, New Brunswick--(BUSINESS WIRE)--Dec
Read more →-OGI
Dec 14, 2020Filed by newsfilecorp.com NOTICE OF CHANGE OF AUDITOR (National Instrument 51-102) TO: Deloitte LLP AND TO: KPMG LLP AND TO: New Brunswick Financial and Consumer Services Commission Ontario Securities Commission British
NOTICE OF CHANGE OF AUDITOR (National Instrument 51-102) New Brunswick Financial and Consumer Services Commission Ontario Securities Commission British Columbia Securities Commission Alberta Securities Commission Financial and Consumer Affairs Authority of Saskatchewan The
Read more →-OGI
Nov 30, 2020Organigram Reports Fourth Quarter 2020 Results Q4 2020 net revenue increased 25% to $20.4 million from $16.3 million in Q4 2019 Q4 2020 gross revenue increased 32% to $25.4 million from $19.2 million in Q4 2019 Launched
Organigram Reports Fourth Quarter 2020 Results Q4 2020 net revenue increased 25% to $20.4 million from $16.3 million in Q4 2019 Q4 2020 gross revenue increased 32% to $25.4 million from $19.2 million in Q4 2019 Launched 40 new stock keeping units ("SKUs") since July 2020, incl
Read more →-OGI
Nov 25, 2020Organigram to Report Fourth Quarter and Full Year Fiscal 2020 Results on
Organigram to Report Fourth Quarter and Full Year Fiscal 2020 Results on November 30, 2020 MONCTON, New Brunswick--(BUSINESS WIRE)--November 24, 2020--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the "Company" or "Organigram"), a lead
Read more →-OGI
Nov 17, 2020Organigram Launches Edison RE:MIX Rapid Dissolvable Cannabis Powder Rapid dissolving and discreet formulations offer consumers highly customizable cannabis beverage experience Nanoemulsion formula offers improved absorpt
Organigram Launches Edison RE:MIX Rapid Dissolvable Cannabis Powder Rapid dissolving and discreet formulations offer consumers highly customizable cannabis beverage experience Nanoemulsion formula offers improved absorption compared to traditional edibles Estimates suggest Can
Read more →-OGI
Nov 12, 2020Filed by newsfilecorp.com ORGANIGRAM HOLDINGS INC. as the Corporation and TSX TRUST COMPANY as the Warrant Agent WARRANT INDENTURE Providing for the Issue of Warrants
ORGANIGRAM HOLDINGS INC. as the Warrant Agent Bay-Adelaide Centre - West Tower 333 Bay Street, Suite 3400 Toronto, Ontario M5H 2S7 ARTICLE 1 INTERPRETATION 2 1.1 Definitions 2 1.2 Gender and Number 6 1.3 Headings, Etc. 7 1.4 Day not a Business Day 7 1.5 Time of the Essence 7
Read more →-OGI
Nov 12, 2020Organigram Closes Previously Announced Underwritten Public Offering MONCTON, New Brunswick--(BUSINESS WIRE)
Organigram Closes Previously Announced Underwritten Public Offering MONCTON, New Brunswick--(BUSINESS WIRE)--November 12, 2020--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer o
Read more →-OGI
Nov 9, 2020Organigram Launches Trailblazer Kushmas Stix and Edison Bytes Gingerbread Truffles -- Two New Limited-Edition Holiday Offerings Trailblazer Kushmas Stix offer pine, sweetness and spice in giftable holiday 0.5g pre-roll E
Organigram Launches Trailblazer Kushmas Stix and Edison Bytes Gingerbread Truffles -- Two New Limited-Edition Holiday Offerings Trailblazer Kushmas Stix offer pine, sweetness and spice in giftable holiday 0.5g pre-roll Edison Bytes Gingerbread Truffles mix delicate spice with m
Read more →-OGI
Oct 30, 2020Organigram CEO Joins Canadian Chamber of Commerce Board of Directors MONCTON, New Brunswick--(BUSINESS WIRE)
Organigram CEO Joins Canadian Chamber of Commerce Board of Directors MONCTON, New Brunswick--(BUSINESS WIRE)--October 30, 2020--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer o
Read more →-OGI
Oct 23, 2020Organigram Confirms Additional $2.5 Million Investment in Hyasynth Biologicals Inc. as Biosynthesis Pioneer Completes First Milestone Linked to First Sale of Commercial Product and Announces Executive Changes Hyasynth In
Organigram Confirms Additional $2.5 Million Investment in Hyasynth Biologicals Inc. as Biosynthesis Pioneer Completes First Milestone Linked to First Sale of Commercial Product and Announces Executive Changes MONCTON, New Brunswick--(BUSINESS WIRE)--October 23, 2020--As an early
Read more →-OGI
Sep 17, 2020Organigram Expands Strong Value Portfolio With Launch of SHRED: High Quality, High Potency, Affordable Pre-shredded Dried Flower MONCTON, New Brunswick--(BUSINESS WIRE)
Organigram Expands Strong Value Portfolio With Launch of SHRED: High Quality, High Potency, Affordable Pre-shredded Dried Flower MONCTON, New Brunswick--(BUSINESS WIRE)--September 17, 2020--In an effort to continue to break down the barriers to purchasing from the legal cannabis
Read more →-OGI
Aug 18, 2020Organigram Joins Medical Cannabis by Shoppers Inc. and TruTrace in Effort to Track Source and Genetics of Cannabis Used by Medical Patients Project aims to match therapeutic outcomes to specific cannabis profiles and ens
Organigram Joins Medical Cannabis by Shoppers Inc. and TruTrace in Effort to Track Source and Genetics of Cannabis Used by Medical Patients Project aims to match therapeutic outcomes to specific cannabis profiles and ensure consistent product for patients and healthcare practiti
Read more →-OGI
Aug 14, 2020Organigram Sends First Shipment of Indoor-Grown Dried Flower to Israeli Cannabis Producer, Canndoc Ltd. MONCTON, New Brunswick--(BUSINESS WIRE)
Organigram Sends First Shipment of Indoor-Grown Dried Flower to Israeli Cannabis Producer, Canndoc Ltd. MONCTON, New Brunswick--(BUSINESS WIRE)--August 14, 2020-- Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the "Company" or "Organigr
Read more →-OGI
Aug 4, 2020Organigram Strengthens Edison Flower Portfolio with Three New High Potency Strains - The General (Grapefruit GG4), Chemdog and Samurai Spy (Ninja Fruit) Company investing in new genetics, and micropropagation with Segra
Organigram Strengthens Edison Flower Portfolio with Three New High Potency Strains - The General (Grapefruit GG4), Chemdog and Samurai Spy (Ninja Fruit) Company investing in new genetics, and micropropagation with Segra as part of its commitment to continuous improvement in prod
Read more →-OGI
Jul 28, 2020Organigram Launches Trailblazer Snax, the Largest, Competitively Priced Cannabis-Infused Chocolate Bar in Canada MONCTON, New Brunswick--(BUSINESS WIRE)
Organigram Launches Trailblazer Snax, the Largest, Competitively Priced Cannabis-Infused Chocolate Bar in Canada MONCTON, New Brunswick--(BUSINESS WIRE)--July 28, 2020--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the "Company" or "Or
Read more →-OGI
Jul 20, 2020Organigram Announces Executive Change MONCTON, New Brunswick--(BUSINESS WIRE)
Organigram Announces Executive Change MONCTON, New Brunswick--(BUSINESS WIRE)--July 20, 2020--Organigram Holdings Inc. ("Organigram" or the "Company") (TSX: OGI) (NASDAQ: OGI) announces that Ray Gracewood, Senior Vice President of Marketing and Communications has left Organigra
Read more →-OGI
Jul 17, 2020Filed by newsfilecorp.com TABLE OF CONTENTS Management's Responsibility for the Financial Statements 1 Condensed Consolidated Interim Statements of Financial Position 2 Condensed Consolidated Interim Statements of (Loss)
Management's Responsibility for the Financial Statements 1 Condensed Consolidated Interim Statements of Financial Position 2 Condensed Consolidated Interim Statements of (Loss) Income and Comprehensive (Loss) Income 3 Condensed Consolidated Interim Statements of Changes in Equity
Read more →-OGI
Jul 3, 2020Organigram Provides Update on COVID-19 Corporate Action Plan and Timing for Q3 Results MONCTON, New Brunswick--(BUSINESS WIRE)
Organigram Provides Update on COVID-19 Corporate Action Plan and Timing for Q3 Results MONCTON, New Brunswick--(BUSINESS WIRE)--July 3, 2020--Organigram Holdings Inc. ("Organigram" or the "Company") (TSX: OGI) (NASDAQ: OGI) provides a corporate update on recent developments of t
Read more →-OGI
Jun 23, 2020Organigram Holdings Inc. Provides Corporate Updates MONCTON, New Brunswick--(BUSINESS WIRE)
Organigram Holdings Inc. Provides Corporate Updates MONCTON, New Brunswick--(BUSINESS WIRE)--June 23, 2020--Organigram Holdings Inc. ("Organigram" or the "Corporation") (TSX: OGI) (NASDAQ: OGI) announces a number of corporate updates. At-the-Market Program Completion Earlier t
Read more →-OGI
Jun 9, 2020Organigram and Canndoc Sign International Strategic Agreement Organigram to supply Israeli leader Canndoc with up to 6,000kg of dried flower in multi-year strategic agreement; Organigram's largest international deal to d
Organigram and Canndoc Sign International Strategic Agreement Organigram to supply Israeli leader Canndoc with up to 6,000kg of dried flower in multi-year strategic agreement; Organigram's largest international deal to date MONCTON, New Brunswick--(BUSINESS WIRE)--June 9, 2020-
Read more →-OGI
May 29, 2020Organigram Successfully Completes Amendment to Credit Facilities with Bank of Montreal Maintains available undrawn capacity of up to $30 million on term loan and $25 million revolving credit facility MONCTON, New Brunswi
Organigram Successfully Completes Amendment to Credit Facilities with Bank of Montreal Maintains available undrawn capacity of up to $30 million on term loan and $25 million revolving credit facility MONCTON, New Brunswick--(BUSINESS WIRE)--May 29, 2020--Organigram Holdings Inc
Read more →-OGI
May 28, 2020Organigram Rolls out Cannabis 2.0 Products to Medical Consumers Edison Cannabis Company vape pens and vaporizer pods, Edison Bytes chocolate now available via Company's medical cannabis program MONCTON, New Brunswick--(B
Organigram Rolls out Cannabis 2.0 Products to Medical Consumers Edison Cannabis Company vape pens and vaporizer pods, Edison Bytes chocolate now available via Company's medical cannabis program MONCTON, New Brunswick--(BUSINESS WIRE)--May 28, 2020--Organigram Holdings Inc. (NAS
Read more →-OGI
May 28, 2020Filed by newsfilecorp.com Execution Copy SECOND AMENDMENT TO CREDIT AGREEMENT This Agreement dated as of
SECOND AMENDMENT TO CREDIT AGREEMENT This Agreement dated as of May 28, 2020 made among: ORGANIGRAM HOLDINGS INC. BANK OF MONTREAL, CANADIAN WESTERN BANK, CONCENTRA BANK and FARM CREDIT CANADA as Administrative Agent WHEREAS the undersigned are parties to the credit agreemen
Read more →-OGI
May 14, 2020Organigram announces first phase of return-to-work strategy Company recalls approximately 50 employees to core roles across organization MONCTON, New Brunswick--(BUSINESS WIRE)
Organigram announces first phase of return-to-work strategy Company recalls approximately 50 employees to core roles across organization MONCTON, New Brunswick--(BUSINESS WIRE)--May 14, 2020--As it continues to monitor and assess the implications of the COVID-19 pandemic, Organ
Read more →-OGI
Apr 30, 2020Court Significantly Reduces Scope of Class Action MONCTON, New Brunswick--(BUSINESS WIRE)
Court Significantly Reduces Scope of Class Action MONCTON, New Brunswick--(BUSINESS WIRE)--April 30, 2020--The Nova Scotia Court of Appeal has partially overturned the certification of a class action (the "Class Action") against Organigram Inc. (the "Company" or "Organigram") an
Read more →-OGI
Apr 23, 2020Consumer Research Drives Enhancements to Organigram Adult Recreational Commercial Portfolio New initiatives include niche and value brand entries, as well as initial production of new form factors MONCTON, New Brunswick-
Consumer Research Drives Enhancements to Organigram Adult Recreational Commercial Portfolio New initiatives include niche and value brand entries, as well as initial production of new form factors MONCTON, New Brunswick--(BUSINESS WIRE)--April 23, 2020--Organigram Holdings Inc.
Read more →-OGI
Apr 22, 2020Filed by newsfilecorp.com ORGANIGRAM HOLDINGS INC. $49,000,000
ORGANIGRAM HOLDINGS INC. EQUITY DISTRIBUTION AGREEMENT Ladies and Gentlemen: Organigram Holdings Inc., a corporation continued under the Canada Business Corporations Act ("Organigram" or the "Corporation"), confirms its agreement (this "Agreement") with BMO Nesbitt Burns Inc.
Read more →-OGI
Apr 14, 2020Filed by newsfilecorp.com ORGANIGRAM'S PORTFOLIO OF ADULT RECREATIONAL CANNABIS BRANDS: The Edison Cannabis Co. is a premium and modern brand for discerning consumers. Focused on the pillars of quality, sophistication, c
ORGANIGRAM'S PORTFOLIO OF ADULT RECREATIONAL CANNABIS BRANDS: The Edison Cannabis Co. is a premium and modern brand for discerning consumers. Focused on the pillars of quality, sophistication, creativity and innovation, Edison delivers quality and a contemporary cannabis experi
Read more →-OGI
Apr 7, 2020Organigram Provides Update on Corporate Action Plan in Response to COVID-19 Pandemic Also provides details for Q2 Fiscal 2020 earnings conference call scheduled for
Organigram Provides Update on Corporate Action Plan in Response to COVID-19 Pandemic Also provides details for Q2 Fiscal 2020 earnings conference call scheduled for April 14, 2020 MONCTON, New Brunswick--(BUSINESS WIRE)--April 6, 2020--Organigram Holdings Inc. (NASDAQ: OGI) (TS
Read more →-OGI
Mar 23, 2020Organigram Receives Health Canada License Renewal and Expansion for Final Elements of Phase 5 and Provides COVID-19 Update MONCTON, New Brunswick--(BUSINESS WIRE)
Organigram Receives Health Canada License Renewal and Expansion for Final Elements of Phase 5 and Provides COVID-19 Update MONCTON, New Brunswick--(BUSINESS WIRE)--March 23, 2020--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the "Comp
Read more →-OGI
Mar 10, 2020Ideal Potency of Edible Products 5MGs of THC or Less, Organigram Consumer Research Survey Concludes Survey canvased over 2,000 Canadians on perceptions and attitudes around edible products Results reveal top concerns tha
Ideal Potency of Edible Products 5MGs of THC or Less, Organigram Consumer Research Survey Concludes Survey canvased over 2,000 Canadians on perceptions and attitudes around edible products Results reveal top concerns that may impact purchase decisions, including controlling dos
Read more →-OGI
Mar 4, 2020Organigram Expands Leadership Team with the Appointment of Chief Strategy Officer and Newly Appointed Chief Financial Officer Paolo De Luca, current CFO, appointed Chief Strategy Officer Derrick West, currently on Board
Organigram Expands Leadership Team with the Appointment of Chief Strategy Officer and Newly Appointed Chief Financial Officer Paolo De Luca, current CFO, appointed Chief Strategy Officer Derrick West, currently on Board of Directors, joins as Chief Financial Officer MONCTON, N
Read more →-OGI
Feb 27, 2020Filed by newsfilecorp.com 1A The articles of Organigram Holdings Inc. (the " Corporation ") be amended as follows: (a) To confirm that the authorized capital of the Corporation shall consist of: (i) an unlimited number o
The articles of Organigram Holdings Inc. (the "Corporation") be amended as follows: (a) To confirm that the authorized capital of the Corporation shall consist of: (i) an unlimited number of Common shares; and (ii) an unlimited number of Preferred shares. (b) To delete Schedu
Read more →-OGI
Feb 25, 2020Organigram Holdings Inc. Announces Election of Directors MONCTON, New Brunswick--(BUSINESS WIRE)
Organigram Holdings Inc. Announces Election of Directors MONCTON, New Brunswick--(BUSINESS WIRE)--February 25, 2020--Organigram Holdings Inc. ("Organigram" or the "Corporation") (TSX: OGI) (NASDAQ: OGI) announced today that each of the eight nominees listed in its management inf
Read more →-OGI
Feb 20, 2020Organigram Continues Cannabis 2.0 Roll Out, Releases Edison Vape Pens Powered by Feather, and Edison Bytes to Markets Across Canada Product portfolio demonstrates Company's investment in innovative technology, world-clas
Organigram Continues Cannabis 2.0 Roll Out, Releases Edison Vape Pens Powered by Feather, and Edison Bytes to Markets Across Canada Product portfolio demonstrates Company's investment in innovative technology, world-class product development and production MONCTON, New Brunswic
Read more →-OGI
Feb 3, 2020NOTICE OF ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS to be held on
Table of Contents NOTICE OF ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS to be held on February 25, 2020 INFORMATION CIRCULAR Dated: January 23, 2020 Table of Contents NOTICE OF ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS to be held on February 25, 2020 NOTICE IS HEREBY GIVE
Read more →-OGI
Jan 23, 2020Edison La Strada Selected Favourite THC Flower in Canada 2019 Leafly Readers Choice Awards ranks top cannabis products in Canada, as chosen by consumers Company receives four awards and five acknowledgments, including To
Edison La Strada Selected Favourite THC Flower in Canada 2019 Leafly Readers Choice Awards ranks top cannabis products in Canada, as chosen by consumers Company receives four awards and five acknowledgments, including Top Pre-Roll (Edison El Dorado), Top THC Oil (Edison Sativa)
Read more →-OGI
Jan 16, 2020Organigram secures Supply Agreement with Medical Cannabis by Shoppers Agreement highlights Company's strong commitment to Canada's medical cannabis community MONCTON, New Brunswick--(BUSINESS WIRE)
Organigram secures Supply Agreement with Medical Cannabis by Shoppers Agreement highlights Company's strong commitment to Canada's medical cannabis community MONCTON, New Brunswick--(BUSINESS WIRE)--January 16, 2020--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent
Read more →-OGI
Jan 15, 2020Filed by newsfilecorp.com Organigram Holdings Inc. Management's Discussion and Analysis of Financial Condition and Results of Operations ("MD&A") For the three months ended
ORGANIGRAM'S PORTFOLIO OF ADULT RECREATIONAL CANNABIS BRANDS: The Edison Cannabis Co. is a premium and modern brand for discerning consumers. Focused on the pillars of quality, sophistication, creativity and innovation, Edison delivers quality and a contemporary cannabis experi
Read more →-OGI
Jan 9, 2020Organigram Selected by Canada's Top 100 Employers Atlantic Canada's Top Employer competition recognizes forward-thinking, progressive organizations MONCTON, New Brunswick--(BUSINESS WIRE)
Organigram Selected by Canada's Top 100 Employers Atlantic Canada's Top Employer competition recognizes forward-thinking, progressive organizations MONCTON, New Brunswick--(BUSINESS WIRE)--January 9, 2020--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of
Read more →-OGI
Jan 3, 2020Organigram to Report First Quarter Fiscal 2020 Results on January 14 th , 2020 and Operational Update MONCTON, New Brunswick--(BUSINESS WIRE)
Organigram to Report First Quarter Fiscal 2020 Results on January 14 th , 2020 and Operational Update MONCTON, New Brunswick--(BUSINESS WIRE)--January 3, 2020--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the "Company" or "Organigram"
Read more →-OGI
Dec 23, 2019Organigram Trailblazer Torch Vape Cartridges Among First Cannabis 2.0' Products Company Distributes to Market First wave of Company's vaporizer offerings shipped in accordance with allowable timelines MONCTON, New Brunsw
Organigram Trailblazer Torch Vape Cartridges Among First Cannabis 2.0' Products Company Distributes to Market First wave of Company's vaporizer offerings shipped in accordance with allowable timelines MONCTON, New Brunswick--(BUSINESS WIRE)--December 23, 2019--Organigram Holdin
Read more →-OGI
Dec 13, 2019Organigram Receives Licensing for Chocolate Production and Packaging Area; Increased Production, Drying and Other Post-Harvesting Areas Company receives Health Canada approval for 16 additional cultivation rooms, expande
Organigram Receives Licensing for Chocolate Production and Packaging Area; Increased Production, Drying and Other Post-Harvesting Areas Company receives Health Canada approval for 16 additional cultivation rooms, expanded site perimeter for Phase 5 edibles facility including cho
Read more →-OGI
Dec 4, 2019Filed by newsfilecorp.com ORGANIGRAM HOLDINGS INC. $55,000,000
ORGANIGRAM HOLDINGS INC. EQUITY DISTRIBUTION AGREEMENT Ladies and Gentlemen: Organigram Holdings Inc., a corporation continued under the Canada Business Corporations Act ("Organigram" or the "Corporation"), confirms its agreement (this "Agreement") with BMO Nesbitt Burns Inc.
Read more →-OGI
Nov 25, 2019Organigram Reports Fourth Quarter and 2019 Fiscal Year Results 2019 net revenue grew 547% to $80.4 million from $12.4 million in 2018 2019 gross margin before fair value changes to biological assets and inventory grew 57
Organigram Reports Fourth Quarter and 2019 Fiscal Year Results 2019 net revenue grew 547% to $80.4 million from $12.4 million in 2018 2019 gross margin before fair value changes to biological assets and inventory grew 575% to $37.9 million or 47% of net revenue from $5.6 millio
Read more →-OGI
Nov 11, 2019Organigram Wins Top Product Award in High THC Bottled Oil Category at 2019 Canadian Cannabis Awards Company recognized in eight other categories including Brand of the Year and Employer of the Year Awards validate strate
Organigram Wins Top Product Award in High THC Bottled Oil Category at 2019 Canadian Cannabis Awards Company recognized in eight other categories including Brand of the Year and Employer of the Year Awards validate strategic focus on innovation, quality and commitment to custome
Read more →-OGI
Nov 11, 2019Organigram Provides Corporate Update Announces Earnings Call for Fiscal Q4 and Full Year 2019 Results MONCTON, New Brunswick--(BUSINESS WIRE)
Organigram Provides Corporate Update Announces Earnings Call for Fiscal Q4 and Full Year 2019 Results MONCTON, New Brunswick--(BUSINESS WIRE)--November 11, 2019--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the "Company" or "Organigr
Read more →-OGI
Nov 7, 2019A Strong Step Forward for the Legal Cannabis Market in Ontario Organigram Expects Enhanced Ability to Meet Consumer Demand with Ontario Government's Positive Changes to Cannabis Retail MONCTON, New Brunswick--(BUSINESS W
A Strong Step Forward for the Legal Cannabis Market in Ontario Organigram Expects Enhanced Ability to Meet Consumer Demand with Ontario Government's Positive Changes to Cannabis Retail MONCTON, New Brunswick--(BUSINESS WIRE)--November 7, 2019--Organigram Holdings Inc. (NASDAQ:
Read more →-OGI
Oct 10, 2019Organigram Awarded Excellence in Manufacturing Consortium Award Company recognized in Outstanding EMC Member Contribution and Outstanding Manufacturer Categories for Manufacturing Excellence MONCTON, New Brunswick--(BUSI
Organigram Awarded Excellence in Manufacturing Consortium Award Company recognized in Outstanding EMC Member Contribution and Outstanding Manufacturer Categories for Manufacturing MONCTON, New Brunswick--(BUSINESS WIRE)--October 10, 2019--Organigram Holdings Inc. (NASDAQ: OGI)
Read more →-OGI
Oct 7, 2019Organigram Assumes Board Positions on International Cannabis Industry Advocacy Organizations Organigram now represented on American Trade Association for Cannabis and Hemp, Policy Center for Public Health and Safety and
Organigram Assumes Board Positions on International Cannabis Industry Advocacy Organizations Organigram now represented on American Trade Association for Cannabis and Hemp, Policy Center for Public Health and Safety and European Alliance for Medical Cannabis MONCTON, New Bruns
Read more →-OGI
Sep 9, 2019Organigram Receives Health Canada Approval to Bring Total Licensed Production Capacity to Target of 76,000 kg/yr 1 Facility Expansion Remains on Schedule to Increase Capacity and Further Improve Efficiencies of Scale MON
Organigram Receives Health Canada Approval to Bring Total Licensed Production Capacity to Target of 76,000 kg/yr 1 Facility Expansion Remains on Schedule to Increase Capacity and Further Improve Efficiencies of Scale MONCTON, New Brunswick--(BUSINESS WIRE)--September 9, 2019--O
Read more →-OGI
Aug 20, 2019Organigram Announces Trading Date for Graduation to TSX MONCTON, New Brunswick--(BUSINESS WIRE)
Organigram Announces Trading Date for Graduation to TSX MONCTON, New Brunswick--(BUSINESS WIRE)--August 20, 2019--Organigram Holdings Inc. (NASDAQ: OGI) (TSX VENTURE: OGI), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cann
Read more →-OGI
Aug 8, 2019Organigram Conditionally Approved to Graduate to the TSX MONCTON, New Brunswick--(BUSINESS WIRE)
Organigram Conditionally Approved to Graduate to the TSX MONCTON, New Brunswick--(BUSINESS WIRE)--August 8, 2019--Organigram Holdings Inc. (NASDAQ: OGI) (TSX VENTURE: OGI), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cann
Read more →-OGI
Jul 26, 2019Organigram Signs New Agreement for Access to 60,000kg of CBD-rich Hemp New advance purchase agreement with 1812 Hemp for access to as much as 60,000kg of hemp flower to be harvested in calendar 2019 Organigram maintain
Organigram Signs New Agreement for Access to 60,000kg of New advance purchase agreement with 1812 Hemp for access to as much as 60,000kg of hemp flower to be harvested in calendar 2019 Organigram maintains right of first refusal on 1812 Hemp s In 2018 Organigram purchased 4,3
Read more →-OGI
Jul 12, 2019Filed by newsfilecorp.com ORGANIGRAM S PORTFOLIO OF ADULT RECREATIONAL CANNABIS BRANDS: 1. INTRODUCTION This Management s Discussion and Analysis dated
ORGANIGRAM S PORTFOLIO OF ADULT RECREATIONAL This Management s Discussion and Analysis dated July 12, 2019 (this MD&A ), should be read in conjunction with the condensed consolidated interim financial statements (the Interim Financial Statements ) of Organigram Holdings Inc.
Read more →-OGI
Jul 10, 2019Filed by newsfilecorp.com Organigram and Lift & Co. Enhance Education of Cannabis Frontline Staff via Brand-Specific Training Program Organigram first licensed producer in Canada to deliver brand education through CanSel
Organigram and Lift & Co. Enhance Education of Cannabis Frontline Staff via Brand-Specific Training Program Organigram first licensed producer in Canada to deliver brand education through CanSell platform to front-line retailers CannSell, available to retailers in eight jurisd
Read more →-OGI
Jul 8, 2019Filed by newsfilecorp.com Organigram Announces Expanded Development of Rapid-Onset Nano-Emulsification Technology for Cannabis Beverages Organigram plans for launch of dried powder formulation beverage products in early
Organigram Announces Expanded Development of Rapid-Onset Nano-Emulsification Technology for Cannabis Beverages Organigram plans for launch of dried powder formulation beverage products in early 2020 in Canada Proprietary nano-emulsion technology, developed based on analytical
Read more →-OGI
Jul 2, 2019Filed by newsfilecorp.com Organigram Holdings Inc. to Report Third Quarter Fiscal 2019 Results on
Organigram Holdings Inc. to Report Third Quarter Fiscal 2019 Results on July 15, 2019 MONCTON, NEW BRUNSWICK, JULY 2, 2019/CNW/ Organigram Holdings Inc. (NASDAQ: OGI) (TSX VENTURE: OGI), the parent company of Organigram Inc. (the Company or Organigram ), a leading licensed pr
Read more →-OGI
Jun 24, 2019Filed by newsfilecorp.com Organigram Receives Health Canada Approval for an Additional 17 Cultivation Rooms in Phase 4A Additional licensed cultivation space brings annual target production capacity to 61,000 kg/yr 1 MON
Organigram Receives Health Canada Approval for an Additional 17 Cultivation Rooms in Phase 4A Additional licensed cultivation space brings annual target production capacity to 61,000 kg/yr1 MONCTON, NB, June 24, 2019 Organigram Holdings Inc. (TSX VENTURE: OGI) (NASDAQ: OGI),
Read more →-OGI
Jun 20, 2019Filed by newsfilecorp.com Organigram sends first shipment to Quebec; Organigram products now available in all ten provinces MONCTON, NB
Organigram sends first shipment to Quebec; Organigram products now available in all ten provinces MONCTON, NB, June 20, 2019 - Organigram Holdings Inc. (TSX VENTURE: OGI) (NASDAQ: OGI), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed pr
Read more →-OGI
Jun 18, 2019Filed by newsfilecorp.com Organigram becomes exclusive Canadian supplier of Feather Company s design-patented vaporizer hardware and technology Agreement pairs innovative Edison brand with unique, proprietary delivery me
Organigram becomes exclusive Canadian supplier of design-patented vaporizer hardware Agreement pairs innovative Edison brand with unique, delivery mechanism for discerning & sophisticated consumers MONCTON, June 18, 2019/CNW/ - As the legalization of adult use recreational c
Read more →-OGI
Jun 7, 2019Filed by newsfilecorp.com Organigram Secures Partnership with PAX as Brand Partner Partnership with PAX builds on Organigram s commitment to both quality and a strong leadership position with next generation cannabis pro
Organigram Secures Partnership with PAX as Brand Partnership with PAX builds on Organigram s commitment to both quality and a strong leadership position with next generation cannabis products Organigram plans to offer Edison Cannabis Co. brand PAX Era pods coast to coast, thr
Read more →-OGI
May 31, 2019Filed by newsfilecorp.com ORGANIGRAM HOLDINGS INC. as Borrower - and - THE LENDERS FROM TIME TO TIME PARTY TO THIS AGREEMENT as Lenders - and - BANK OF MONTREAL as Administrative Agent - and - BANK OF MONTREAL as Lead Ar
ORGANIGRAM HOLDINGS INC. THE LENDERS FROM TIME TO TIME PARTY TO THIS AGREEMENT as Administrative Agent as Lead Arranger and Sole Bookrunner ARTICLE I - INTERPRETATION 1.01 Definitions 1 1.02 Accounting Principles 25 1.03 Currency References 25 1.04 Extended Meanings 25 1.05
Read more →-OGI
May 31, 2019Filed by newsfilecorp.com Organigram Closes $140 Million Credit Facility with Bank of Montreal Non-dilutive Financing Provides Company with Significant Financial Flexibility MONCTON, MAY 31, 2019 - Organigram Holdings In
Organigram Closes $140 Million Credit Facility with Bank of Montreal Non-dilutive Financing Provides Company with Significant Financial Flexibility MONCTON, MAY 31, 2019 - Organigram Holdings Inc. (NASDAQ: OGI) (TSX VENTURE: OGI), the parent company of Organigram Inc. (colle
Read more →-OGI
May 31, 2019Filed by newsfilecorp.com Organigram Receives Organic Certification for Recreational Cannabis MONCTON
Organigram Receives Organic Certification for Recreational Cannabis MONCTON, May 31, 2019/CNW/ Organigram Holdings Inc. (TSX VENTURE: OGI) (NASDAQ: OGI), the parent company of Organigram Inc. (the Company or Organigram ), a leading licensed producer of cannabis, is pleased t
Read more →-OGI
May 29, 2019Filed by newsfilecorp.com Organigram fulfills gap in Canadian CBD Market with Edison CBD Oil Company sends initial shipments of more than 130 thousand units MONCTON
Organigram fulfills gap in Canadian CBD Market with Edison Company sends initial shipments of more than 130 thousand MONCTON, May 29, 2019/CNW/ Organigram Holdings Inc. (TSX VENTURE: OGI) (NASDAQ: OGI), the parent company of Organigram Inc. (the Company or Organigram ), a lea
Read more →-OGI
May 21, 2019Filed by newsfilecorp.com CHANGE OF STATUS REPORT PURSUANT TO SECTION 11.2 OF NATIONAL INSTRUMENT 51-102 Organigram Holdings Inc. (the Issuer ) hereby reports, pursuant to section 11.2 of National Instrument 51-102 Conti
CHANGE OF STATUS REPORT PURSUANT TO SECTION 11.2 OF NATIONAL INSTRUMENT 51-102 Organigram Holdings Inc. (the Issuer ) hereby reports, pursuant to section 11.2 of National Instrument 51-102 Continuous Disclosure Obligations, that the Issuer has ceased to be a venture issuer ef
Read more →-OGI
May 17, 2019Filed by newsfilecorp.com Organigram Announces May 21 st as Inaugural Date of Trading on the Nasdaq Global Select Market MONCTON
Organigram Announces May 21st as Inaugural Date of Trading on the Nasdaq Global Select Market MONCTON, May 17, 2019/CNW/ Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQX: OGRMF), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed prod
Read more →Competitive Position
How OGI ranks across every disease it competes inCompetitive Position is a premium feature
See how OGI ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial